Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
06/06/2012 | EP2458995A1 Trisubstituted boron-containing molecules |
06/06/2012 | EP2458992A1 Treatment of crohn's disease with laquinimod |
06/06/2012 | EP2458988A1 Treating critically ill patients with intravenous ibuprofen |
06/06/2012 | EP2458983A1 Inhibitors of cognitive decline |
06/06/2012 | EP2334674B1 Pyridazino- pyridinone compounds for the treatment of protein kinase mediated diseases. |
06/06/2012 | EP2231640B1 Beta-amino acid derivatives for treatment of diabetes |
06/06/2012 | EP2220092B1 Azaindolizines and methods of use |
06/06/2012 | EP2213679B1 Water-soluble triterpenephenol compounds having antitumor activity and the preparation thereof |
06/06/2012 | EP2205599B1 Cgrp antagonists |
06/06/2012 | EP2137188B1 Substituted imidazopyrimidines and triazolopyrimidines |
06/06/2012 | EP2114423B1 Product containing inactivated probiotic for infants |
06/06/2012 | EP2016052B1 Crystalline (3-cyano-1h-indol-7-yl)-[4-(4-fluorophenethyl)piperazin-1-yl]methanone phosphate |
06/06/2012 | EP2004693B1 Compositions and methods of use for antibodies of c-met |
06/06/2012 | EP2001842B1 2-methylene-1alpha-hydroxy-19,21-dinorvitamin d3 analogs and uses thereof |
06/06/2012 | EP1909912B1 Use of collismycin A as oxidative stress inhibitor |
06/06/2012 | EP1863493B1 Corticosteroid containing formulation for treating psoriasis, eczema, ulcer and burns. |
06/06/2012 | EP1858879B1 1,3-diaryl substituted ureas as modulators of kinase activity |
06/06/2012 | EP1794174B1 Methods and compositions for inhibition of innate immune responses and autoimmunity |
06/06/2012 | EP1789433B1 Methods of treating cutaneous flushing using selective alpha-2-adrenergic receptor agonists |
06/06/2012 | EP1751149B1 Bicyclic-substituted amines having cyclic-substituted monocyclic substituents |
06/06/2012 | EP1716235B1 Inhibitors of tgf-r signaling for treatment of cns disorders |
06/06/2012 | EP1711188B1 Anti-cancer therapies |
06/06/2012 | EP1663291B1 Recombinant lubricin molecules and uses thereof |
06/06/2012 | EP1633718B1 COMPOSITIONS AND METHODS FOR INHIBITING TGF-s |
06/06/2012 | EP1620108B1 Pyrazole-amine compounds useful as kinase inhibitors |
06/06/2012 | EP1594462B1 Surgical implant compprising an anabolic and a corticosteroid |
06/06/2012 | EP1593127B1 Radiation protection by gamma-tocotrienol, alpha-tocopherol succinate or gamma-tocopherol succinate |
06/06/2012 | EP1575526B1 Dna vaccines encoding heat shock proteins |
06/06/2012 | EP1557415B1 Heterocyclic compounds and antitumor drugs containing the same as the active ingredient |
06/06/2012 | EP1548024B1 Pyrazole derivatives, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof |
06/06/2012 | EP1531798B1 Pulmonary delivery for levodopa |
06/06/2012 | EP1477164B1 Percutaneous absorption type plaster |
06/06/2012 | EP1463558B1 Cytotoxic agents bearing a reactive polyethylene glycol moiety, cytotoxic conjugates comprising polyethylene glycol linking groups, and methods of making and using the same |
06/06/2012 | EP1389462B1 Amorphous cefditoren pivoxil composition and process for producing the same |
06/06/2012 | EP1261259B2 Treatment of infection in animals |
06/06/2012 | DE102010062288A1 Verwendung von Zytokine-freisetzenden, biodegradierbaren Partikeln in Hyaluronsäure zur Behandlung von Knorpeldefekten, insbesondere von Osteoarthrose Use of cytokine release, biodegradable particles in hyaluronic acid for the treatment of cartilage defects, particularly osteoarthritis |
06/06/2012 | DE102010053567A1 Formulation and device, useful for local increase of efficiency and practical use of preventive or mitigation measure against hypoglycemia, comprise a sprayable formulation comprising a mixture of a sugar and a sodium ion releasing salt |
06/06/2012 | DE102010053347A1 3-Hetaryl-substituierte Pyrrolo[2,3-b] pyridin-derivative als PDK1-Inhibitoren 3-hetaryl-substituted pyrrolo [2,3-b] pyridine-derivative as PDK1 inhibitors |
06/06/2012 | CN202263199U Compound Clarinex pseudoephedrine sulfate sustained release tablet pharmaceutical composition |
06/06/2012 | CN202263198U Complex gastrointestinal capsule containing combination of diclofenac sodium and acetaminophen |
06/06/2012 | CN202263197U Double-layered packaged compound naproxen capsule |
06/06/2012 | CN202262925U 一种医用杀虫止痒湿巾 A medical insecticidal itching wipes |
06/06/2012 | CN1997651B Oxidative degradation products of atorvastatin calcium |
06/06/2012 | CN1984682B Solid medicinal preparation |
06/06/2012 | CN1939304B Ascending-dose dosage form |
06/06/2012 | CN1784228B Novel compositions |
06/06/2012 | CN1738628B Compositions and methods for combination antiviral therapy |
06/06/2012 | CN1681484B Orally administrable composition for improving skin quality |
06/06/2012 | CN1582282B Novel mandelate salts of substituted tetracyclic tetrahydrofuran derivatives |
06/06/2012 | CN1545508B 1,2,4-trioxolane antimalarials |
06/06/2012 | CN1535149B Topical application of thiazolyl amides |
06/06/2012 | CN1342158B 4-heterocyclysulfonamidyl-6-methoxy-5-(2-methoxy-phenoxy)-2-pyridyl-pyrimidine derivatives, their preparation and use as endothelin receptor antagonists |
06/06/2012 | CN1309563B Use of 1-(aminoalkyl)-3-quinoxaline-2-one derives for preparation of compounds having antioxidant action |
06/06/2012 | CN102485741A Methyl reduced oleanane triterpenoid, its preparation method and application |
06/06/2012 | CN102485735A 6-fructosamine-4-arylamidoquinazoline derivative and purpose thereof |
06/06/2012 | CN102485734A Compound for increasing bone mineral density and synthetic method thereof |
06/06/2012 | CN102485724A Substituted thiazolyl pyrazolo pyridine compound and medical purpose thereof |
06/06/2012 | CN102485721A Substituted 2,3-phthalazinone compounds and application thereof |
06/06/2012 | CN102485720A Heat shock protein 90 inhibitor |
06/06/2012 | CN102485717A Thiazolamine derivative and application thereof as sRNA virus infection resisting medicine |
06/06/2012 | CN102485271A Emergency medicine used for treating snakebite, and preparation method thereof |
06/06/2012 | CN102485246A Traditional Chinese medicine composition gel used for treating gynecologic diseases, and preparation method thereof |
06/06/2012 | CN102485245A Traditional Chinese medicine composition gelata for treating gynecological inflammations |
06/06/2012 | CN102485244A Application of Chinese medicinal composition in preparing gel for treating gynecological inflammation |
06/06/2012 | CN102485242A Chinese medicinal composition for dispelling wind, clearing heat, removing toxins, and benefiting throat, and preparation method thereof |
06/06/2012 | CN102485241A Traditional Chinese medicine composition having functions of dispelling wind, clearing heat, removing toxins and benefiting throat and preparation method thereof |
06/06/2012 | CN102485239A Chinese herbal composition used for treating gynecological inflammation |
06/06/2012 | CN102485236A Medicine composition for treating burns, scalds, carbuncle, furuncle, furunculosis, and herpes zoster |
06/06/2012 | CN102485234A Composition used for preventing and/or treating liver damage caused by acute hepatitis |
06/06/2012 | CN102485233A Anti-HIV medicinal composition |
06/06/2012 | CN102485232A Medicinal composition containing decitabine |
06/06/2012 | CN102485231A Discocleidion sufescens Pax et Hoffm. extract, preparation method thereof and purpose thereof |
06/06/2012 | CN102485230A Medicine for burns and scalds |
06/06/2012 | CN102485229A Antiviral medicine |
06/06/2012 | CN102485228A Pharmaceutical composition and purpose thereof |
06/06/2012 | CN102485227A Medicine composition and applications thereof |
06/06/2012 | CN102485226A Compound artemisinin piperaquine pellet and preparation method thereof |
06/06/2012 | CN102485225A Pharmaceutical composition used for treating bacteria infection |
06/06/2012 | CN102485224A Method for preparing micronized oxazolidinone medicines and micronized pharmaceutical composition |
06/06/2012 | CN102485223A Pharmaceutical composition and application thereof to preparation of medicament for treating cerebrovascular disease |
06/06/2012 | CN102485222A Novel purpose of 3-methyl-1-phenyl-2-pyrazoline-5-ketone |
06/06/2012 | CN102485221A Sublingual pharmaceutical composition containing ibutilide and preparation method thereof |
06/06/2012 | CN102485220A Nimesulide monolayer osmotic pump controlled release tablet |
06/06/2012 | CN102485219A Diltiazem hydrochloride delayed release bilayer osmotic pump controlled released tablet and its preparation method |
06/06/2012 | CN102485218A Clopidogrel hydrogen sulfate tablet and preparation method thereof |
06/06/2012 | CN102485217A Letrozole tablet with high dissolubility and preparation method thereof |
06/06/2012 | CN102485216A Taste-modifying medicine tablets |
06/06/2012 | CN102485215A Etodolac timed-release pellet and preparation method thereof |
06/06/2012 | CN102485213A Irinotecan liposome and preparation method thereof |
06/06/2012 | CN102485212A Sunitinib malate liposome and preparation method thereof |
06/06/2012 | CN102485211A Doxorubicin liposome and its preparation method |
06/06/2012 | CN102485210A Voriconazole intravenous injection submicron emulsion and its preparation method |
06/06/2012 | CN102210669B Application of salvia extract in treating septicemia |
06/06/2012 | CN102144967B Veterinary long-acting compound doxycycline injection and preparation method thereof |
06/06/2012 | CN102120022B Medicament for treating pain and fever caused by cancer |
06/06/2012 | CN102106985B Medicament for treating alopecia |
06/06/2012 | CN102068411B Carbazole sulfonamide type anti-tumor medicament granules and preparation method thereof |
06/06/2012 | CN102038697B Anti-anxiety medicament and application thereof |
06/06/2012 | CN102020765B Preparation methods of poly (aspartic acid-co-lactic acid) graft polymer and nanoparticles of poly (aspartic acid-co-lactic acid) graft polymer |
06/06/2012 | CN102008725B Application of human UTP14a expression inhibitor in preparation of cell proliferation inhibitor |